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Identifying a Neurotoxic Mechanism Present 
in West Nile Neuroinvasive Disease
Jasmine Brown
Mentors: Robyn S. Klein and Charise Garber
More than half of patients who survive West Nile neuroinvasive Disease exhibit chronic 
cognitive impairments, such as spatial learning deficits. With various studies implicating 
interferon gamma (IFNg) in a mechanism responsible for cognitive deficits following 
viral infection, the lab studied WNV-infected interferon gamma receptor knockout 
(IFNgR-/-) mice to determine if signaling through this receptor contributed to spatial 
learning deficits. All IFNgR-/- mice were protected from spatial learning defects. I used 
this global gene deletion model to determine gene expression downstream of IFNg 
that confers poor learning. Brain tissue was harvested from these mice at 7, 25 and 52 
days post-infection. Virus is present in the brain at day 7 but cleared by day 25 and 
52. I used this tissue to determine the changes in gene expression for an array of genes 
suspected to underlie memory dysfunction. I also studied Cx3Cr1-CreER-IFNgRfl/fl mice, 
which have IFNgR conditionally deleted from microglia and are also protected against 
spatial learning deficits. This allowed me to evaluate how interferon gamma signaling, 
specifically to microglia, plays a role in the cognitive deficits observed in WNV infected 
mice. I assessed changes in microglia activating gene expression in these microglia-
specific knockout mice. The global knockout mice exhibited decreased expression of 
complement regulatory and microglia activating genes during early recovery. These 
results suggest that elevated expression of complement regulatory and microglia 
activation genes during early recovery may contribute to the spatial learning deficits 
present in wild type (WT) mice following WNV infection. Elucidating this neurotoxic 
mechanism is vital to the development of therapies for people experiencing cognitive 
deficits following WNV infection.
